[company_age]7.0[/company_age][employees]2-10 employees[/employees][funding]Series A[/funding][description]SunRegen Healthcare AG is a biopharmaceutical company based in Basel Area, Switzerland. It focuses on developing innovative treatments for patients suffering from neurological, neuromuscular, and ophthalmic diseases. The company's first product candidates in development target primary optical atrophy, and it is further evaluating them for use in serious neurological/neuromuscular diseases such as ALS, Huntington's, Alzheimer's, and Parkinson's disease.\n\nSunRegen Healthcare AG is a unique company in several ways. First, it is focused on developing treatments for a wide range of neurodegenerative diseases. Second, the company's team is composed of passionate and innovative founders and experts who have solid track records in drug development and clinical research in multinational pharmaceutical companies or management experience in international technology enterprises. Third, the company is committed to bringing life-changing treatments to patients.[/description][ps]SunRegen Healthcare AG is developing drug candidates for the treatment of neurodegenerative diseases.[/ps]